Gene Therapy Latest News | Experimental Gene Therapy Studies

New Gene Therapy Shows Promise in Hemophilia A Mouse Model, Study Shows

17 March 2020

Human Gene Therapy for Hemophilia

04 February 2020

High Dose of Gene Therapy for Hemophilia B Normalizing FIX Levels, Early Trial Data Show

18 February 2020

BioMarin Submits Biologics License Application to U.S. Food and Drug Administration for Valoctocogene Roxaparvovec to Treat Hemophilia A

02 January 2020

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
02 January 2020
BioMarin submits EMA filing for first hemophilia gene therapy
18 December 2019
Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs
17 November 2019
Patient perspectives on novel treatments in hemophilia A: a qualitative study
17 November 2019

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL